|
|
Use of adrenergic receptor alpha2-agonists in pain treatment
Soláriková, Ivana ; Vaculín, Šimon (advisor) ; Maršáková, Lenka (referee)
α2-adrenergic receptor agonists are adjuvant analgesics involved in the modulation and treatment of pain acting in the noradrenergic system. Binding of α2 agonists to receptors initiates a cascade of actions leading i.a. to antinociception. The most clinically applied analgesics of this type include clonidine, dexmedetomidine, and xylazine used in veterinary medicine. The ability to potentiate the effects of opioid and nonopioid analgesics and anesthetics leading to dose reduction is especially advantageous as it relieves unpleasant side effects associated with opioid use, and reduces the risk of tolerance development. They are effective in local anesthesia due to the peripheral site of action and do not cause characteristic, centrally mediated side effects of hemodynamic character. They are involved in the suppression of inflammatory response in the body by inhibiting the production of proinflammatory cytokines. Despite the wide range of action, α2 agonists appear to be safe in many different contraindications, such as sepsis, diabetes or pregnancy. Keywords: α2-adrenergic receptors, agonists, pain, analgesia, clonidine, dexmedetomidine, potentiation, adjuvant
|
|
|
Use of adrenergic receptor alpha2-agonists in pain treatment
Soláriková, Ivana ; Vaculín, Šimon (advisor) ; Maršáková, Lenka (referee)
α2-adrenergic receptor agonists are adjuvant analgesics involved in the modulation and treatment of pain acting in the noradrenergic system. Binding of α2 agonists to receptors initiates a cascade of actions leading i.a. to antinociception. The most clinically applied analgesics of this type include clonidine, dexmedetomidine, and xylazine used in veterinary medicine. The ability to potentiate the effects of opioid and nonopioid analgesics and anesthetics leading to dose reduction is especially advantageous as it relieves unpleasant side effects associated with opioid use, and reduces the risk of tolerance development. They are effective in local anesthesia due to the peripheral site of action and do not cause characteristic, centrally mediated side effects of hemodynamic character. They are involved in the suppression of inflammatory response in the body by inhibiting the production of proinflammatory cytokines. Despite the wide range of action, α2 agonists appear to be safe in many different contraindications, such as sepsis, diabetes or pregnancy. Keywords: α2-adrenergic receptors, agonists, pain, analgesia, clonidine, dexmedetomidine, potentiation, adjuvant
|
|
| |
guest ::
